Sharonova I N, Vorobjev V S, Haas H L
Department of Neurophysiology, Heinrich-Heine-Universität, Düsseldorf, Germany.
Eur J Neurosci. 1998 Feb;10(2):522-8. doi: 10.1046/j.1460-9568.1998.00057.x.
The actions of Cu2+ ions on GABAA receptor-mediated currents in acutely isolated Purkinje cells from rat cerebellum were studied using the whole-cell patch-clamp technique and a rapid perfusion system. Bath application of Cu2+ reduced currents induced by 2 microM gamma-aminobutyric acid (GABA) in a concentration-dependent manner with an IC50 of 35 nM. The Cu2+-induced block of GABA responses was not voltage-dependent. Increasing the GABA concentration (from 2 to 50 microM) decreased the blocking effect of Cu2+. Dose-response analysis for activation of GABAA receptors revealed a twofold decrease in apparent affinity for GABA in the presence of 0.1 microM Cu2+. Recovery from the block required several minutes after removal of Cu2+ from the medium. The block was removed by histidine, which preferentially forms complexes with Cu2+, or by other chelating substances. Application of 10 microM histidine immediately before application of 2 microM GABA completely relieved the block of GABA responses produced by 0.1 microM Cu2+. The effect of histidine was concentration-dependent with an EC50 of 0.75 microM. The results demonstrate that Cu2+ is a potent inhibitor of GABA-evoked responses in rat Purkinje cells. Copper may be an endogenous synaptic modulating factor. Cu2+ toxicity, notably in Wilson's disease, could result to some extent from chronic GABAA receptor blockade.
采用全细胞膜片钳技术和快速灌流系统,研究了Cu2+离子对急性分离的大鼠小脑浦肯野细胞中GABAA受体介导电流的作用。浴槽施加Cu2+以浓度依赖性方式降低了由2 microMγ-氨基丁酸(GABA)诱导的电流,IC50为35 nM。Cu2+诱导的GABA反应阻断不依赖电压。增加GABA浓度(从2 microM增加到50 microM)可降低Cu2+的阻断作用。对GABAA受体激活的剂量反应分析显示,在存在0.1 microM Cu2+的情况下,对GABA的表观亲和力降低了两倍。从阻断中恢复需要在从培养基中去除Cu2+后几分钟。阻断可通过优先与Cu2+形成复合物的组氨酸或其他螯合物质去除。在施加2 microM GABA之前立即施加10 microM组氨酸可完全解除0.1 microM Cu2+对GABA反应的阻断。组氨酸的作用具有浓度依赖性,EC50为0.75 microM。结果表明,Cu2+是大鼠浦肯野细胞中GABA诱发反应的有效抑制剂。铜可能是一种内源性突触调节因子。Cu2+毒性,特别是在威尔逊病中,可能在一定程度上源于慢性GABAA受体阻断。